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SUMMARY 
This essay examines the issue of trial participation in the proposed my Vaccine Trials in 
South Mrica. It is set against the backdrop of ethical issues relating to research in the 
Third World in general. 
Trial participation is examined in the context of the ethical tension that exists between 
international ethical research standards based on Liberal Individualism and local 
standards of care and cultural norms in the Third World. Two areas of conflict are 
inherent here: universality versus particularity on the one hand and individualism versus 
communitarianism, on the other. 
The Tuskegee Syphilis Study as well as the mv Vertical Transmission Trials are used as 
a point of departure to set the stage for the controversy surrounding the proposed my 
Vaccine Trials. 
The important concepts of informed consent, the risk-benefit ratio and fair treatment of 
trial participants are framed within the Four Principle Approach of autonomy, 
beneficence, non-maleficence and justice. These principles form the cornerstone of the 
Declaration of Helsinki. This Western ethical guideline - grounded in universality - has 
become the mantra of all liberal democracies the world over and is chanted slavishly by 
the international research corpmunity. It bears the hallmark ofliberal individualism with 
its mandate that "the concern for the interest of the individual must always prevail over 
the interests of science and society". Followed to its logical conclusion, any 
infringements of the moral interests of trial participants must be viewed using a subject-
oriented approach. Such an approach sees the trial participant as being of paramount 
importance and views research as "highly desirable but morally optional". 
Stellenbosch University  https://scholar.sun.ac.za
Clearly, this would mean the end of the road for medical research, especially in the Third 
World, where a truly subject oriented approach would render research tantamount to 
exploitation of vulnerable, educationally disadvantaged persons. 
In Africa, in traditional, rural communities, a moderate form of communitarianism 
referred to as "Ubuntu" or "communalism" is still prevalent. In such communities, the 
concept of personhood is embedded in the community or society. In these communities, a 
balancing approach, in which infringements on the rights of trial participants are 
permissible in the name of science or society, provided the subject is not placed at 
significant risk, would be acceptable. However, liberal indivldualism is making inroads 
here too. As such, the ethical tension between liberal individualism and 
communitarianism, which is unavoidable in research settings, is growing. 
This essay highlights many internal contradictions in liberal individualism - especially 
where research ethics is concerned in Third World countries. One of the outcomes of 
such contradiction is the attempt by the World Medical Association to amend the 
Declaration of Helsinki - in the name of ethical relativism: different standards for 
different countries or cultures. 
Surely, such liberal individualism cannot be seen as the "endpoint of mankind's 
ideological evolution" as Fukuyama phrases it, nor can it be the final solution to the 
problems of the world and, as such, "the end of history". 
In the context of the mv Vaccine Trials, individual good clashes with societal good, 
universality with particularity and ultimately, modernism with postmodernism. 
In Western cultures, the individual enjoys priority; in other cultures, society is more 
important - somewhere in between, we need to find common ground which can be 
incorporated into a balancing approach with minimal risk to the individual when 
infringement of rights is unavoidable. 
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OPSOMMING 
Hierdie werkstuk ondersoek die kwessie van deelname aan die voorgestelde kliniese HIV 
Entstof-proewe in Suid-Afrika. Die ondersoek geskied teen die agtergrond van die etiese 
kwessies wat opgeroep word deur navorsing in die Derde Wereld in die algemeen. 
Deelname aan hierdie kliniese proewe word ondersoek binne die konteks van die etiese 
spanning way bestaan tussen intemasionale navorsingstandaarde, wat gebaseer is op 
liberale individualisme aan die een kant, en die standaarde van sorg en kulturele norme in 
die Derde Wereld, aan die ander kant. Twee konflikareas is inherent aan hierdie 
spanning: enersyds universaliteit versus partikulariteit en andersyds individualisme 
versus kommunitarisme. 
Die Tuskegee Sifilis Studie en dieHIV Vertikale Oordragproewe word gebruik as 'n 
vertrekpunt om die kontroversie rondom die voorgestelde HIV Entstofproewe te 
bespreek. 
Die belangrike konsepte van ingeligte toestemming, die risiko-voordeel ratio en die 
regverdige behandeling van deelnemers aan die proewe word bespreek binne die Vier 
Beginsel Benadering van outonomiteit, die plig om goed te doen ("beneficence"), die plig 
om nie kwaad te doen nie ("non-maleficence") en regverdigheid. Hierdie beginsels vorm 
die hoeksteen vir die Verklaring van Helsinki. Hierdie Westerse etiese riglyne, wat 
gegrond is in universaliteit, het die mantra geword van aile liberale demokrasiee die 
wereld oor en word slaafs nagevolg deur die intemasionale navorsingsgemeenskap. Dit 
dra die stempel van liberale individualisme met sy mandaat dat "die belang van die 
individu altyd moet voorkeur geniet bo die belange van wetenskap en die samelewing". 
Die logiese konklusie van hierdie argument is dat enige beperking op die morele belange 
van die deelnemers aan hierdie pro ewe, beskou moet word in die lig van 'n subjek-
georienteerde benadering. So 'n benadering beskou die proewe-deelnemers as van 
kardinale belang ensien navorsing as "hoogs wenslik, maar moreel opsioneel". 
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Dit impliseer egter die einde van mediese navorsing, vera I in die Derde Wereld, 
aangesien 'n ware subjek-georienteerde benadering sal veroorsaak dat navorsing neerkom 
op die uitbuiting van kwesbare, opvoedkundig benadeelde persone. 
In Afrika koin 'n gemagtigde vorm van kommunitarisme, wat beskryf word as "ubuntu" 
of "pia as like selfbestuur" ("communalism") steeds voor in tradisionele, landelike 
gemeenskappe. In sulke gemeenskappe is die konsep van persoonsyn ingebed in die 
gemeenskap of samelewing. In hierdie gemeenskappe is 'n meer gebalanseerde 
benadering eerder gewens, dit wil se, 'n benadering waar skendings van die regte van 
proewe-deelnemers toelaatbaar is is die naam van die wetenskap of die samelweing 
toelaatbaar is, mits die subjek nie in 'n te groot gevaar geplaas word nie. Liberale 
individualisme begin egter ook hier 'n toenemende invloed uit te oefen. Die etiese 
spanning tussen liberale individualisme en kommmunitarisme, wat onafwendbaar is in 'n 
navorsingsomgewing, word in werklikheid al hoe groter. 
Hierdie werkstuk wys op talle interne teenstrydighede wat voorkom in liberale 
individualisme, veral ten opsigte van navorsingsetiek in die Derde Wereld. Een van die 
gevolge van so 'n teenstrydigheid, is die poging deur die Wereld Mediese Vereniging om 
" die Verklaring van Helsinki te wysig in die naam van etiese relativisme en te vra vir 
verskillende standaarde vir verskillende lande en kulture. 
Sekerlik kan sodanige liberale individualisme nie beskou word as die "endpoint of 
mankind's ideological evolution ", soos Fukuyama dit stel nie ook nie as die finale 
oplossing van die wereld se probleme en as sodanig die "einde van geskiedenis" nie. 
In die konteks van die mv Entstofproewe, is daar 'n botsing tussen dit wat goed is vir 
die individu en dit wat goed is vir die samelewing, tussen universaliteit en particulariteit 
en uiteindelik tussen universaliteit en partikulariteit en uiteindelik tussen modernisme en 
postmodemisme. 
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In die Westerse kultuur geniet die individu die hoogste prioriteit, maar in ander kulture is 
die samelewing belangriker. Dit is egter no dig dat ons iewers in die middel 'n gedeelde 
grondslag vind wat geinkorporeer kan word in 'n meer gebalanseerde benadering, met 
minimale risiko vir die individu, veral in die gevalle waar en wanneer dit onvermydelik is 
om inbraak te maak op indiviuele regte. 
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ABSTRACT 
Set in the context of ethical issues relating to research in the Third World, this paper 
examines the thorny issue oftrial participation in the proposed HIV Vaccine Trials in 
South Africa. Such participation is viewed against the backdrop of the ethical tension that 
exists between international ethical standards based on Liberal Individualism and local 
standards of care and cultural norms in the Third World. Conflict exists between 
universality and particularity, on the one hand, and between individualism and 
communitarianism on the other. 
The Tuskegee Syphilis Study as well as the HIV Vertical Transmission Trials are used as 
a point of departure to set the stage for the controversy surrounding the proposed mv 
Vaccine Trials. 
The important concepts of informed consent, the risk-benefit ratio and fair treatment of 
trial participants are framed within the Four Principle Approach of autonomy, 
beneficence, non-maleficence and justice - which forms the cornerstone of the 
Declaration of Helsinki. This Western ethical guideline - grounded in universality - has 
become the mantra of all liberal democracies the world over and is chanted slavishly by 
the international research community. With its mandate that the "concern for the interest 
of the individual must always prevail over the interests of science and society", it bears 
the hallmark ofliberal individualism. Followed to its logical conclusion, any 
infringements of the moral interests of trial participants must be viewed using a subject-
oriented approach. Such an approach sees the trial participant as being of paramount 
importance and sees research as "highly desirable but morally optional". 
Clearly, this would mean the end of the road for medical research, especially in the Third 
World, where a truly subject oriented approach would render research tantamount to 
exploitation of vulnerable, educationally disadvantaged persons. 
In Africa, in traditional, rural communities, a moderate form of communitarianism 
referred to as "Ubuntu" or "communalism" is still prevalent. In such communities, the 
2 
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concept of personhood is embedded in the community or society. A balancing approach, 
in which infringements on the rights of trial participants are permissible in the name of 
science or society, provided the subject is not placed at significant risk, would be 
acceptable in these communities. However, liberal individualism is making inroads here 
too. As such, the ethical tension between liberal individualism and communitarianism, 
which is unavoidable in research settings, is growing. 
This essay highlights many internal contradictions in liberal individualism - especially 
where research ethics is concerned in the setting of Third World countries. One of the 
outcomes of such contradiction is the attempt by the World Medical Association to 
amend the Declaration of Helsinki - in the name of ethical relativism: different standards 
for different countries or cultures. 
Surely, such liberal individualism cannot be seen as the "endpoint of mankind's 
ideological evolution" as Fukuyama phrases it, nor can it be the final solution to the 
problems of the world and as such, "the end of history". 
In the context ofthe HIV Vaccine Trials, individual good clashes with societal good, 
universality with particularity and ultimately, modernism with postmodernisrn. 
In Western cultures, the individual enjoys priority; in other cultures, society is more 
important - somewhere in between, we need to find common ground which can be 
incorporated into a balancing approach with minimal risk to the individual when 
infringement of rights is unavoidable. 
3 
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HIV Vaccine Trial Participation in the Third World - An Ethical Assessment. 
INTRODUCTION 
With 16000 new people infected daily throughout the world, mY/AIDS is increasingly 
being recognised as an illness of global importance and is regarded as a major priority 
for the world community. It is generally accepted that an effective preventive my 
vaccine could be a powerful tool in the struggle against the expanding my pandemic. 
However, such a vaccine would have to be tested in clinical trials using human subjects 
in the absence of a suitable animal model. 
Recruiting volunteers for these trials is critical to the success of the endeavour, yet it is 
fraught with scientific, social, political and ethical concerns - especially when the target 
communities live in the Third World. 
Possible host community responses range from "opposition and obstruction, to 
indifference, support or active participation" (Hodel 1994: 255). 
For individual participants, a wide range of factors might influence a decision to 
participate - concerns about adverse reactions, anxiety about the possibility of being 
infected by the vaccine and a host of "social harms" like discrimination by friends, 
family, employers, life or health insurance companies, blood banks and restriction on 
international travel (Hodel 1994: 255). 
Thus, to achieve truly informed consent, it is critical to determine what information is to 
be given to potential volunteers in order for them to make an informed decision. A vital 
component of such patient information is the risk-benefit ratio that determines the ethical 
acceptability of clinical research. In AIDS vaccine research, however, the half of the 
.... equation that deals with risk is "virtually unknown". There is no data about the potential 
for risks such as "vaccine-induced immunotoxicity or antibody-induced enhancement of 
infection" (Tacket and Edelman 1990:356). 
There is also no guarantee that those participants who do become infected during the trial 
will receive expensive anti-retroviral treatment that is not the standard of care in most 
developing countries. 
4 
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It is thus evident that the proposed HlV vaccine trials in the developing world will be 
inundated with ethical concerns. 
In anticipation of the launch ofHIV vaccine trials worldwide, guidelines have been 
developed to ensure that "ethical issues do not impede the development of a new 
vaccine"! (United Nations Programme on AIDS - UNAIDS). 
These ethical guidelines are designed to protect the rights of those participating in 
international vaccine trials and are based on the Helsinki Declaration of 1975, which 
mandates that "concern for the interest of the individual must always prevail over the 
interests of science and society". As such the issues central to this endeavour include, 
inter alia, individual informed consent, obligations of trial sponsors to host countries to 
provide vaccines, if they prove to be effective, and the use of expensive antiretroviral 
treatment for participants in developing countries who become infected during the trials. 
In keeping with the ethos of the host country - the United States - the ideal ofliberal 
individualism reigns supreme. The emphasis has clearly and strategically been placed on 
the protection of the rights of trial participants. Informed consent is detailed as follows -
participants must be given a subject information sheet, a third party advisor must be 
accessible, participants should have time to reflect on their decisions and then give 
written informed consent. 
In reality, however, the issue of obtaining informed consent from trial participants in 
developing countries is frightening! How does one explain the intricacies ofrandomised 
placebo controlled vaccine trials to vulnerable, poorly educated, deprived individuals 
who barely understand the concept of a "virus" let alone a "vaccine". 
In spite of this, investigators believe that "one cannot allow our inability to solve these 
problems to slow the progress of clinical trials - we need to recognise the complexity and 
respect norms while still proceeding with trials"! (Ron Bayer - HlV Centre, New York, 
1998). 
It does not seem to occur to such investigators that one cannot proceed with these trials 
without informed consent. Vaccine development must proceed but certainly not efficacy 
trials if important ethical issues are not resolved. 
5 
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The paradox inherent in this endeavour involves the high priority placed on the 
individual and the rights of the individual, to achieve, ultimately, not only societal good 
but global good. 
How do we ask the individual to simultaneously evaluate the process of informed 
consent, to reflect on a trial in which s/he is to be exposed to risks of unknown magnitude 
and vaccines of doubtful benefit - and make a decision to best protect him/herself - in a 
scientific research trial which, historica:Ily, involves the use of human subjects to enhance 
the general welfare of society? 
The ethical dilemma central to this essay revolves around individual good as opposed to 
societal good - stated in established Western terms. Does this dilemma or this distinction 
even exist in the Third World, in general, and in South Mrica, in particular? In spite of 
the fact that 10% of the world's mv infection occurs in South Mrica, what value is 
attached to individual good or societal good in a community entrenched in an ethos of 
fatalism where the threat to life posed by HIV is no greater than the threat to life which 
exists on a daily basis? 
On a deeper philosophical level, what will be the outcome of the wave ofliberal 
individualism that is spreading rapidly across the world? The burgeoning human rights 
culture that has taken root across the globe has many ardent supporters, even in cultures 
where communitarianism is valued in some form or another. On the African Continent, 
and in South Africa, in particular, we are familiar with the concept of "Ubuntu" ,.-" I am 
because we are". This concept favours communal values over Western individualism. In 
fact, the individual exists only in the context of the community. However, even these 
communities have been influenced by the Western ideals of individualism and 
materialism. 
Are we now going to ask the people of Africa, who are not necessarily in agreement with 
Western concepts, to first and foremost consider their individual rights and then give 
informed consent to participate in vaccine trials which will benefit all of humankind? My 
fear is that they may have consented, on altruistic grounds alone, at an earlier place in 
6 
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time. However, now, given the risks to themselves as individuals, will they still consent 
without a material inducement they have been taught to value by the West? 
A study conducted in Thailand amongst potential volunteers in a phase 1 mv vaccine 
trial to explore their motivations for participation in these trials found that personal 
benefit as opposed to altruistic motives were important (Jenkins 1995: 36-42). 
This finding was echoed in another study that looked at willingness of high-risk 
populations to participate in AIDS vaccine trials in Thailand. This study found that "the 
principal inducement to join a trial was health insurance" (Celentano 1995: 1079-1083). 
Yet another study, also conducted in Thailand, to look at Hepatitus B Immunization as a 
potential incentive for trial participation, concludes that "concrete health benefits may 
offer the most compelling incentives to volunteers" (Beyrer 1996:399). 
Undoubtedly, the search for incentives has begun! 
If this occurs, if some form of manipulation is employed to ensure participation, where is 
the element ofvoluntariness in the informed consent thus obtained? Can ethical trials be 
conducted in this fashion? 
This essay examines the issue of trial participation in proposed mv vaccine trials in 
South Africa against the backdrop of the ethical tension that exists between international 
ethical standards based on Liberal Individualism and local standards of care and cultural 
norms in the Third World. Many of the principles of African "Communitarianism" or 
-
Ubuntu, which exists in various forms especially in rural, traditional South African 
communities, are in stark contrast to the individualistic principles of the West. Yet, the 
individualism of the West has influenced African cultures to a significant degree. Our 
Constitution and Bill of Rights bear testimony to this. As a result, it is no longer easy for 
Western countries to engage in research in Africa without respecting the culture of 
human rights which has developed here. This change in emphasis from the community to 
the individual has started to influence research opportunities and possibilities in the Third 
World. Fulfilling all the criteria of international guidelines for the performance of ethical 
research in the Third World is starting to become problematic. How will the West 
respond? Will ethical relativism become a viable option and a convenient solution? 
7 
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In order to place the ethical concerns of the mv vaccine trials in perspective, the 
historical Tuskegee Syphilis Study will be used as a point of departure. The Vertical 
Transmission ofHIV Trials will be briefly revisited to highlight the attention being 
focused on research ethics in the Third World. The classical "Four Principles" approach 
will then be examined to explore ethical concerns central to the HIV vaccine trials and its 
relevance in the African context will be discussed. 
Limitations on the individual's moral interests will be explored using three possible 
moral frameworks - the societal view, the subject-oriented approach and a balancing 
approach - with an interplay between the benefits ofthe subject and society. 
Ultimately, the idea that an appeal to "Ubuntu" might be our only hope of conducting 
ethical mv vaccine trials in South Africa will be explored. However, will this retreat to 
ethical relativism be acceptable to the people of Africa? 
8 
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3. RESEARCH ETHICS IN DEVELOPING COMMUNITIES 
3.1 Introduction 
Developing communities around the world are seen as excellent candidates for medical 
research largely because of the unfortunate but typical characteristics of these 
communities - they tend to be over-populated, poor, malnourished, illiterate and 
desperate. Under these conditions, together with a fragile health-care infrastructure, 
diseases thrive, especially infectious diseases. Under these conditions, empirical scientific 
research also thrives - statistically significant data can be obtained from large- scale 
clinical trials on thousands of human "volunteers". 
As a result of this, 
" Residents of impoverished, postcolonial countries, the 
majority of whom are people of color, must be protected 
from potential exploitation in research. Otherwise, the 
abominable state of health care in these countries can be 
used to justify studies that could never pass ethical muster 
in the sponsoring country." 
Lurie and Wolfe - 1997 
Public Citizen's Health Research Group 
These sentiments were expressed in the New England Journal of Medicine in September 
1997 when a heated debate was sparked by trials in the developing world on mv 
infected pregnant women to assess if short-course anti-retroviral treatment could reduce 
the transmission ofHIV from mother to child. The ethical concerns raised by these trials 
were seen by some members of the medical profession as reminiscent of ethical concerns 
raised many years earlier by the Tuskegee Study. 
9 
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3.2 The Tuskegee Syphilis Study 
This study has been described as the longest running "nontherapeutic experiment" on 
human beings in medical history and "the most notorious case of prolonged and knowing 
violation of subject's rights" (Caplan 1992: 29). 
The Tuskegee Study of Untreated Syphilis was sponsored by the United States Public 
Health Service. The study began in 1932 and continued till 1972. OVer this 40 year 
period of human experimentation, 412 African-American men with untreated Syphilis 
were observed and compared with 204 men who were free of disease to determine the 
natural history of syphilis. When the study began, there was no good treatment available 
except for heavy metals, which were the standard of treatment. However, "the research 
continued even after penicillin became widely available and was known tobe highly 
effective against syphilis". The study continued until it was brought to the attention of a 
reporter. The "outrage provoked by front-page stories in the Washington Star and the 
New York Times embarrassed the Nixon administration into calling a halt to it"(Angell 
1997: 847-849). 
The ethical violations here occurred not in a developing country outside the United 
States, but rather in a disadvantaged "developing" community inside the developed First 
World continent. 
According to Marcia Angell in an editorial in the New England Journal afMedicine of 
September 1997," the ethical violations were multiple: subjects did not provide informed 
consent (indeed, they were deliberately deceived); they were denied the best known 
treatment; and the study was continued even after highly effective treatment became 
available" . 
A special article in the Hastings Centre Report in 1992 confirms that subjects were 
recruited with misleading promises of "special free treatment" which, in reality, consisted 
of spinal taps done without anaesthesia to study the neurological effects' of syphilis. 
An article in the New York Times published on the 26 July 1972 describes the various 
incentives which were used to ensure trial participation - " free transportation to and from 
10 
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hospitals, free hot lunches, free medicine for any disease other than syphilis and free 
burial after autopsies were performed". 
The ethical violations inherent in the Tuskegee study were clearly in contravention of the 
Declaration of Helsinki (1964) which states that "the interests of the subject must 
always prevail over the interests of science and society"( Gillon 1986: 11). 
On the other hand, the researchers involved in the Tuskegee study argued that the 
African-American men in the study probably would not have been treated anyway, so 
investigators were "merely observing what would have happened if there was no study". 
The study itself was regarded as important, a" never- to- be~ repeated opportunity", 
especially after Penicillin became available. 
In order to see the paralells in research subsequently conducted in the Third World,it is 
necessary to look at the mv Vertical Transmission Trials. 
11 
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3.3 HIV Vertical Transmission Trials In Pregnant Women 
In 1994, the results of the first randomised placebo controlled study on pregnant women 
infected with mv were published. It was established that treatment of these women with 
the antiretrovir'al drug Zidovudine during pregnancy and delivery reduced the 
transmission of the virus from mother to child by 67%. From this point onwards, 
Zidovudine became the best proven standard of treatment for all mv infected pregnant 
women in the United States (Connor,et al 1994: 1173-1179). 
The drug regime used in this landmark study is, however, very expensive and totally 
unaffordable to Third World countries. The next logical step was therefore to investigate 
the possibility of shorter and hence cheaper courses oftreatment. As a result, 16 trials 
were launched in developing countries around the world. 15 of these 16 trials were 
randomized and placebo controlled. mv infected pregnant women in the study group 
were given a short course ofZidovudine and the incidence of transmission of the virus to 
their babies was established. However, the pregnant women in the control group were 
given a placebo. And, this is where the controversy began (Lurie and Wolfe 1997: 853). 
In order to understand the context of the debate, it is essential to look briefly at the basic 
ethical principles of randomised clinical trials. It is an essential pre-requisite that when a 
randomised clinical trial compares two different treatments for a disease that there should 
be no good reason for thinking that one is better than the other. Hence, investigators need 
to be in this state of clinical "equipoise" when embarking on a randomised clinical trial. 
If there is any evidence that one option might be better than the other, then "not only 
would the trial be scientifically redundant, but the investigators would be guilty of 
knowingly giving inferior treatment to some participants in the trial" (Angell 1997: 847). 
This rule applies to placebo-controlled trials as well. It is only ethical to compare a 
potential new treatment with a placebo when there is no known effective treatment. When 
effective treatment exists, a placebo may not be used and subjects in the control group 
must be given the best known treatment (Angell 1997: 847). Such a study is termed an 
equivalency study and the results are scientifically valid. 
12 
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TheIS placebo-controlled trials were conducted even though it had been established that 
Zidovudine could significantly reduce the transmission ofmV from mother to child. 
-According to Marcia Angell, the justifications for these trials are "reminiscent of those 
for the Tuskegee study: Women in the Third World would not receive anti-retroviral 
treatment anyway, so the investigators are simply observing what would happen to the 
subject's infants if there were no study. And a placebo-controlled study is the fastest, 
most efficient way to obtain unambiguous information that will be of greatest value in the 
Third World."(Angell 1997: 847). 
Several arguments have been advanced both for and against these trials but fall outside 
the scope of this paper and will not be pursued any further. 
Both Tuskegee and the mv Vertical Transmission Trials have been discussed to place in 
perspective the importance and relevance of ethical research in the Third World. I believe 
that it is as a direct result of the controversy ignited by the mv Trials discussed above 
that much attention is being devoted to the proposed Vaccine Trials and research in 
general in the Third World. 
International guidelines drafted as early as 1947 in the form of the Nuremberg Code and 
modified 20 years later in the form of the Helsinki Declaration, for the purpose of setting 
universal standards where human experimentation is concerned, have been shown to be 
problematic in the aforementioned Vertical Transmission Trials. It would appear as 
though research in the Third World is now becoming difficult. 
While the Tuskegee experiment continued for 40 years before the ethical violations were 
exposed, the HIV Vertical Transmission Trials provoked an almost immediate and 
dramatic response from the medical profession itself. Hence, it is not surprising that even 
with the Vaccine Trials still years away in South Africa, ethical deliberation has already 
begun! Undoubtedly, the ethical component of clinical research in the developing world 
is gaining impetus. 
It is with these ethical tensions in mind that I will examine the ethical issues pertinent to 
the proposed Vaccine Trials. 
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4.HIV Vaccine Trials in the Third World - the Four Principles Approach? 
4.1 Introduction 
The Nuremberg Code of 1947 requires that biomedical research be conducted in a 
manner consistent with four ethical principles: autonomy, beneficence, non-maleficence 
and justice (Loue 1996: 49). The applicability of these basic ethical principles within 
different cultural settings is increasingly being questioned. This is especially so because 
the international bodies who formulated these principles were unfamiliar with the 
different settings in which they would have to be applied (Barry 1988: 1083). 
The Nuremberg Code, for that matter, was drafted in 1947 by the judges involved in the 
Nuremberg Doctors' Trial. The Declaration of Helsinki was written nearly 20 years later 
and was prompted by the limitations of the Nuremberg Code to provide specific 
guidelines to practitioners in the conduct of ethicalresearch. 
Hence, while the Declaration of Helsinki was the result of a medical professional body 
attempting to regulate itself, it was not without shortcomings. Many concepts are not 
clear, in particular, there is no guidance on how to resolve conflicts resulting from an 
attempt to maximise more than one principle simultaneously (Kunstadler 1980: 289-96). 
In spite of this, the Declaration of Helsinki has become the benchmark for ethical practice 
in research (London 1999: 812). 
As such, it is important to establish whether this Western standard based on the Four 
Principles approach may be appropriately applied to biomedical research in developing 
countries. 
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4.2 Respect for Autonomy and Informed Consent 
Translated from its Greek roots the word "autonomy" refers to self- rule. Western society 
emphasises autonomy - individual rights, self-determination and privacy- in its 
conception of personhood. The Nuremberg Code and its progeny require that 
participation in biomedical research be based on "freedom of individual choice, with no 
element of coercion or constraint. It dictates further that a person should understand the 
subject matter of the research sufficiently to make an enlightened decision"(Barry 1988: 
1083). Hence all the details of the trial- the nature, duration and purpose of the trial, the 
methods that will be used, the possible effects on health and all the inconveniences 
entailed by the experiment - must be made known to the participant. 
Such a conception of autonomy reflects the "basic premise of individual 
sovereignty"(Loue 1996: 49). 
Applying this concept of autonomy and the requirements of informed consent can prove 
to be problematic in many cultures in the Third World where personal choice is 
extremely limited. In many African cultures the concept of personhood differs 
substantially from that in Western cultures. Personhood is defined by one's tribe, village 
or social group. In Western terms, selfhood emphasizes the individual. However, in 
certain African societies, selfhood cannot be extricated from a dynamic system of social 
relationships, both of kinship and of community as defined by the village (Barry 1988: 
1083). This African concept of personhood is further elaborated by Augustine Shutte in 
his work on Ubuntu : persons exist only in relation to other persons. According to him, in 
all African languages, there is the local variant of the Nguni saying "umuntu ngumuntu 
ngabantu" - a person is a person through persons (urlpublished data). 
Similarly, in Ugandan culture, the wishes of the individual are often subordinated to 
those of the immediate or extended family. As such, participation of an individual in 
biomedical research may depend on the acquiescence or consent of another family 
member (Loue 1996: 49). 
However, the concept of family consent is not peculiar to Africa alone. Family consent is 
an important concept in Japanese culture as well where it is seen as a reflection of the 
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role of family in Japanese society in general. As such, the principle of autonomy, as it 
exists in its traditional North American paradigm, is not entirely applicable to Japanese 
culture. Instead, Edmund Pellegrino refers to "something close to autonomy" that is 
respected in the context of Japanese society (Akabayashi 1999: 296-301). 
Similarly, ancient Chinese medical ethics, established on the foundations of Confucian 
ethics, emphasises a respectful attitude towards one's patients based on an unconditional 
value for human life, but does not include respecting their autonomous choices (Tsai 
1999: 315-321). 
It is thus clear that where the notion of persons as individuals is not dominant, the 
consent process may shift from the individual to the family or community (Christakis 
1988: 34). 
Thus, an investigator seeking informed consent from individual persons in such settings 
may need to approach community elders for their consent before attempting to obtain 
informed consent from individual persons (Barry 1988: 1083). 
The person acknowledged to be a "community leader" will vary from one culture to 
another. Whether this person meets the investigator's expectation regarding who can 
appropriately give proxy consent is another complicating factor. 
In order to acknowledge the need for family consent in biomedical research in Uganda, a 
mandatory waiting period of 48 hours is allowed before an informed consent form is 
signed should the potential participant desire this option. This waiting period is, however, 
not without problems - transport to outlying areas may not be available, the entire 
process is costly and time consuming and, as a result, potential participants may abandon 
the trial altogether. Furthermore, the nature of the information regarding the trial may 
have been misunderstood in one sense or another, and in subsequent transmission to a 
family member or significant other, may undergo further modification. Under such 
circumstances, truly informed consent will not be obtained. However, with no suitable 
alternatives, this 48 hour waiting period remains an option when obtaining informed 
consent in Uganda. 
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An essential prerequisite related to proxy consent in Uganda is that a research participant 
must give his/her consent to participate; another individual could not consent for an 
unwilling individual (Loue 1996: 49). Nicholas Christakis echoes this sentiment in his 
appraisal of the ethical design of an AIDS vaccine trial in Africa. 
Having established who will consent to participation in a research trial, it is essential to 
present the details of the trial to the prospective participant sothat such consent is 
informed. This represents the "information elemerit" of informed consent when material 
information is disclosed. Coupled to this disclosure is the element of understanding on 
the part of the patient (Beauchamp & Childress 1994: 145). 
During a workshop held in South Africa to discuss ethical issues in mv vaccine trials in 
September 1998, Oliver Ransome, the medical ombudsman, outlined the prerequisites for 
obtaining informed consent - a subject information sheet; third party adviser; time to 
reflect and the actual written consent. The details on the information sheet should include 
the overall purpose of the research" in comprehensible language". Confidentiality should 
be stressed and it should be clear that the subject is free to decline or withdraw. Questions 
should be invited and time should be allowed for reflection. 
He highlights essential and crucial components of a subject information sheet, however, 
in South Africa, with very high rates of illiteracy, such a sheet may be inappropriate to 
use. In a similar workshop in Uganda, it was established that with their currently "high 
rate of illiteracy, many prospective rese~rch participants would be unable to read a form 
and understand it"(Loue 1996: 50). This would also have serious implications for 
obtaining the "written consent" referred to by Ransome. 
Loue goes on to state that "Ugandans seem generally reluctant to affix their signatures to 
any document" especially one that "confirms their connection to foreigners". He also 
elaborates on the concept of "face agreement" in Uganda. Reluctance to signal one's 
agreement in writing may indicate "face agreement". This could be a reflection of 
cultural standards of etiquette or could reflect a "reluctance to make one's opinion known 
in negotiations characterised by an imbalance of power between the negotiating parties". 
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Most importantly, "face agreement" may result from an inability or unwillingness to 
comply with the terms of a written document and might increase the likelihood that 
research participants will later withdraw from the study (Loue 1996: 50). 
Iliteracy coupled with language barriers in Africa, make the description of AIDS related 
studies difficult. When concepts like germ theory, viruses and vaccines are alien, it is 
indeed challenging to respond to Mark Heywood's (AIDS Law Project, University of the 
Witwatersrand) question on what is sufficient information for informed consent? Ron 
Bayer (HIV Centre, New York) also expresses concern regarding the explanation of 
"complicated scientific methods such as randomisation, placebos, vaccine inefficiency, 
the fact that participation in one trial may exclude future participation in trials of more 
effective vaccines and discrimination linked to participation". 
An interesting problem with language was illustrated in the mv Vertical Transmission 
Trials conducted on pregnant women in South Africain 1997. In a report in the Mail and 
Guardian, October 1997, an attempt was made to justify the trials by explaining that 
informed consent was indeed obtained from trial participants. The placebo drug used in 
these trials was translated to the pregnant women as being a "spaza" drug or a "chuff-
chuff'drug. While a "chuff-chuff' drug is understood to be a "pretend" drug, the word 
"spaza" is a colloquial term generally meaning "half the real thing" or a pretence of the 
real thing. It owes its derivation to the "spaza shops" which abound in most Black 
townships and which mimic real supermarkets. These "spaza shops", although expensive, 
are however, extremely functional and serve a vital purpose in townships generally 
located great distances from the formal shopping complexes and the central business 
districts. In no way are they associated with the concept of inertness inherent in a 
placebo. As such, the use of the term "spaza" to describe a placebo is clearly misleading. 
Participants might have been under the impression that they were receiving a weaker 
form of the active study drug instead ofthe fact of the matter which was simply that they 
were not receiving any drug at all. 
Hence it is evident that the provision of information in a cross-cultural, Third World 
setting could prove to be a daunting task at the best oftimes! 
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An important point made by Heywood during the Vaccine Trial Workshop mentioned 
earlier is that informed consent should not be seen as static or stable but rather as a 
process which varies according to individual needs and circumstances. This beliefwas 
echoed by Graham Lindegger (psychologist - University of Natal). He sees informed 
consent as a process which requires an in-depth understanding of how people make 
decisions. The process should begin with disclosure, followed by understanding in the 
absence of coercion and should culminate in consent.(Lindegger 1998; Vaccine Trial 
Workshop Document). 
Beauchamp and Childress, in their description of informed consent, extend the process 
described by Lindegger by including two preconditions or threshold elements -
competence (to understand and decide) and voluntariness (in deciding). 
In the Third World, where research participants are usually poor, desperate and 
dependent, voluntariness is a significant precondition for obtaining truly informed 
consent. Such voluntariness implies independence from the manipulative and coercive 
influences of others. Research participants should be able to choose freely amongst 
alternatives and also have a right to refuse to participate. 
Of the three forms of influence that may occur in a research setting, manipulation tends to 
occur rather than coercion or persuasion. In the context of decision-making in health care, 
informational manipulation tends to be the key form of manipulation employed. 
Misleading research participants, as in the case of using the word "spaza" to describe a 
placebo, is a form of deception that is clearly inconsistent with autonomous choice. 
Decisions are typically made in a context of competing influences, such as personal 
desires, familial constraints, legal obligations and institutional pressures. Where decision-
making by patients and subjects is concerned, it is importantto establish the point at 
which autonomous choice is impaired - although it is often difficult to draw a clear 
boundary between controlling and non-controlling influences. In research in developing 
communities; the prospective participants' subjective resistance to influence must be 
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assessed, not the objective resistance to influence or the reasonable person's ability to 
resist. 
According to Beauchamp and Childress, the most difficult problem regarding 
manipulation in research is the effect of rewards, offers and encouragement. 
A flagrant illustration of an unjustified offer occurred during the aforementioned 
Tuskegee Syphilis experiment. Subjects were offered free burial assistance and insurance, 
free transportation to and from the examinations and a free stop in town on the return trip. 
e ' 
They were rewarded with free medicines and free hot meals on the day of the 
examination. The socioeconomic deprivation of these subjects made them vulnerable to 
these overt and unjustifiable forms of manipulation (1994: 166-167). 
While it is easy to differentiate between various forms of influence theoretically, many 
borderline cases exist in practice, especially in research settings. An offer that is made in 
a setting in which it is abnormally attractive is clearly manipulative, but not coercive as 
there is no threat involved. Attractive offers such as free medication or extra money can 
leave persons without any meaningful choice apart from accepting the offer largely 
because such persons are constrained in a desperate situation. Whatever we may decide to 
call this, itis widely held that offers of this magnitude to a person in desperate need is 
inherently exploitative and is not consistent with autonomous choice. 
In Uganda; it was decided that the low income of many people as well as the 
disempowered status of women could preclude a truly free decision to participate in a 
research trial. As a result, incentives, in the context of participant recruitment and 
retention, was deemed problematic due to the resultant absence of a perceived choice in 
decision-making. Incentives which were approved of included reimbursment for wages 
lost as a direct result of study participation, such as attendance at study clinics or 
interviews; reimbursement for transportation costs to the study site and meals at the study 
site when the individual was required to be at the study site during a regular meal time. 
Other forms of incentives were found to be "so extraordinary as to be coercive" (perhaps 
manipulative would be a more appropriate term), including cash payments, bicycles and 
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Coupled with this is a need for empowerment of patients so that they can exercise their 
decision-making rights. 
It is evident from this discussion on the procurement of informed consent from 
prospective participants in mv vaccine trials that the concept is riddled with intricacies. 
The precise demands of the principle of autonomy are largely unsettled and remain "open 
to interpretation and specification". 
That the process of informed consent requires time in ideal circumstances, and more so 
in underdeveloped communities, is undeniable. Massive education campaigns, as well as 
the recruiting and training of translators from withirttarget communities with their 
involvement throughout the study period will be vital to the ethical performance of such 
trials in South Africa. Only then can understanding of research procedures be ensured, 
only then will true informed consent be obtained. 
There is no doubt that where informed consent is concerned, we need to avoid the 
pressure to act unethically because of the urgency of the situation (Heywood 1998: 6). 
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4.3 Non-maleficence and Beneficence 
While non-maleficence is associated with the maxim of primum non nocere - "first, do 
no harm", beneficence encompasses both an obligation to do good and an obligation to 
protect research participants from harm. 
Researchers need to make efforts to secure the well-being of research participants. This 
entails achieving a favourable balance between the risks and benefits bfthe proposed 
research (Loue 1996: 50). 
What dsks will be faced by participants in an HIV Vaccine Trial? 
To begin with, adverse effects of the vaccine itself may occur as with other vaccines in 
current use, such as pain or infection at the injection site, fever or allergic reactions. 
Although studies undertaken in the United States have indicated that the vaccines used 
have "relatively few short-term side effects of minor functional consequence, the public 
perception is one of wariness with regard to their safety" (Jenkins 1995: 36). 
A study conducted in Thailand among high-risk populations to assess willingness to 
participate in AIDS vaccine trials found that 25% of the 2180 subjects interviewed would 
definitely join a trial if asked. An additional 38% would accept an AIDS vaccine if they 
were convinced it would be safe and effective. Vaccine side effects were considered to be 
important barriers to trial participation with up to 60% of the study sample being 
concerned about short-term side effects and up to 55% being worried about long-term 
side effects-like permanent injury or death (Celentano 1995: 1079). 
More specifically, with an mv vaccine, participants are likely to be concerned about 
actually developing HlV disease from the vaccine. With the current use of genetically 
altered or killed vimses, this risk is unlikely. The current subunit vaccine candidates, 
which employ genetically engineered proteins from the mv envelope - with a piece of 
25 
Stellenbosch University  https://scholar.sun.ac.za
the virus being used - are likely to allay much anxiety. However, participants' fears are 
likely to magnify as vaccine developers incorporate the use of whole killed or live 
attenuated virus. Already, scientists are becoming impatient to test live attenuated virus 
vaccines! However, leading clinicians are still hesitant regarding the safety of such 
vaccines. While some scientists have demonstrated immune protection lasting for more 
than 7 years in monkeys vaccinated with live attenuated SIV, the monkey analogue of 
mv, at least two unpublished studies on monkeys raise concerns about a fraction of 
animals who actually develop disease in time (Wadman 1997: 426}. In support of this, 
Ruth Ruprecht, of Boston has data on 18 monkeys exposed as adults to live-attenuated 
virus. After a follow up period of 18 months, "one animal has developed early-stage 
immune problems and another has full-blown AIDS". Hence, it is not surprising that the 
majority opinion at present is that "there is just not enough evidence that a live-attenuated 
mV-l vaccine is safe-or effective"(McCarthy 1997: 1082). 
Even with current genetically engineered vaccines, while it is possible that disease will be 
prevented, infection might still occur. In fact, vaccines rarely prevent infection, instead, 
they prevent or modify disease. In general, vaccines tend to "reduce the number of 
invading micro-organisms, increase the rate of clearance of the infection, prevent the 
secondary consequences of infection or prevent transmission. Similarly, few of the 
candidate mv vaccines appear promising for preventing infection, and the expectation 
that mv vaccines will in fact prevent infection is yielding, in the scientific community, 
to the hope that they may prevent disease" (Bloom 1998: 186). 
In reality, when the first AIDS vaccine trials were launched in the United States and 
Thailand in 1998, using the mv envelope protein, gp120 in a vaccine called AIDSV AX, 
two outcome measures were to be assessed - "infection by mv and viral load in those 
infected" . 
Furthermore, the possibility of vaccine failure is a very real one and the occurrence of 
"breakthrough HIV infections" or disease cannot be excluded. 
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This particular risk to the subject needs to be assessed in the context of the different types 
of trials that are performed. 
Safety (phase 1) trials and immunogenicity (phase 2) trials usually are conducted in 
developed countries using small numbers of people at low risk of mv infection. Efficacy 
(phase 3) trials, on the other hand, require large numbers of participants at high risk to 
develop mv infection. It is reasonable to assume that the risk of developing mv 
infection during the course of phase 1 or 2 trials by low risk participants will be far 
greater than the risk taken by people entering phase 3 trials, already at high risk by virtue 
of lifestyle or other predisposing factors. 
This brings us to the crucial question regarding mv vaccine trials in the Third World -
will researchers have an obligation to provide anti-retroviral treatment to subjects who 
become infected during the course of the trials? 
Scientists and ethicists are clearly divided on this point. 
Scientists and researchers are concerned that treatment with anti-retroviral drugs will 
compromise the ability of the trial to measure the efficacy of the vaccine in preventing 
disease (Bloom 1998: 186). 
A critical measure of the success of an AIDS vaccine trial would be whether the vaccine 
lowers the "viralload" - the amount of HI V in the blood - in people who get infected. 
Anti-retroviral treatment will also lower the viral load. If many of the participants who 
become infected begin taking potent anti-retroviral drugs, reduction in viral loads due to 
the vaccine cannot be assessed. Scientists fear that it will become impossible to design a 
"scientifically valid" trial if there is widespread use of anti-ret rovira I drugs. 
However, the head of the biotech company VaxGen, that launched the first efficacy trials 
of an AIDS vaccine in the United States, argued that not everyone would start treatment 
immediately, and because researchers would be taking blood from participants every 24 
weeks or so, they should be able to make at least one viral load measurement in many 
untreated people who become infected (Cohen 1998: 22). 
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Delaying drug treatment until viral loads can be measured, as is implicit in the trial 
design by VaxGen, however, only adds to the complex ethical problems already inherent 
in treating participants who develop mv infection during the trials. 
This delayin treatment will pose problems in the developed world, in particular, because 
in developed countries, it will be ethically required that individuals in vaccine trials who 
have acquired HIV infection will be offered anti-retroviral therapy. It is also expected 
that a delay in treatment will not be tolerated in the West. 
Can these problems be circumvented by conducting trials in the developing world, where 
resources are not available to provide anti-retroviral drugs? 
The standard of care in the developing world is clearly "no treatment for mV/AIDS". 
This will also obviate the ethical dilemma of delaying treatment to measure viral load. 
A perfect solution, it would seem! 
However, ethical guidelines on human experimentation in international research, do not 
condone this. The two documents most influential in this regard are the Declaration of 
Helsinki, promulgated by the World Medical Association in 1964 and the "International 
Ethical Guidelines for Biomedical Research Involving Human Subjects" published by the 
Council for International Organizations of Medical Sciences (CIOMS), in collaboration 
with the World Health Organization (WHO), in 1982. 
The most recent version of the CIOMS guidelines, prepared in 1993, is explicitly 
intended to indicate how the ethical principles of the declaration can be applied 
effectively in developing countries. 
These documents are accepted by the international medical community as providing for 
the highest standards of medical ethics in human experimentation. 
CIOMS Guideline 14 quotes article II.3 of the Helsinki Declaration and states that, "In 
any medical study, every patient - including those of a control group, if any - should be 
assured of the best proven diagnostic and therapeutic method"(Bloom 1998: 186-187). 
In mY/AIDS, this constitutes anti-retroviral triple therapy. 
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Various attempts have been made to circumvent the application of these ethical 
guidelines where mv / AIDS is concerned. However, in many cases such arguments 
revolve around semantics of what the "best proven diagnostic and therapeutic method" 
constitutes. Other arguments against treating trial participants who develop infection 
regard the treatment as an undue influence to encourage trial participation. 
Ultimately, the crucial issue is one of economics. Multinational drug companies are not 
prepared to invest the large sums of money necessary to perform research in keeping with 
the existing ethical guidelines. 
This question oftreating trial participants with anti-retroviral drugs if they develop 
infection during the trials remains largely unanswered. During a workshop "in South 
Africa in 1998, the issue was skirted, stating that this issue would be left up to the host 
country to decide. 
An idea of what is likely to happen in South Africa may be extrapolated from what is 
already happening in Thailand. In a large trial funded by VaxGen, neither the company 
nor the cash-strapped Thai government plans to give cutting-edge treatments to people 
who become infected. 
It is obvious that setting a lower standard for poor countries would create a slippery slope 
- when the level of ethics is set below the maximum, it's very easy to lower it more 
(Cohen 1998: 23). 
More complicated than the actual physical and medical side-effects of vaccination, are 
the so called "social harms" that may burden participants in a vaccine trial. 
These may result from simple participation in trials or from testing HIVpositive as a 
result of vaccination. Individuals whose participation in vaccine trials becomes known 
may be identified as high risk for AIDS, or may be mistakenly assumed to have AIDS. In 
a study conducted in Thailand in 1995 amongst high-risk populations to assess 
willingness to participate, 24-49% believed that their partners would refuse to have sex 
with them after immunization (Celentano 1995: 1079). 
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Discrimination based on my antibody status may occur in a number of settings -
acceptance into the military, the job corps, the peace corps or the foreign service; the 
purchase of life, health or disability insurance; permission to immigrate or travel abroad 
or incarceration (occasionally even arrest, particularly for sex crimes). It is clear that 
volunteers who develop antibodies as a result of vaccination may be at added risk for 
discrimination (Hodel 1994: 256). While it is possible to distinguish between my 
positive results from a vaccine as opposed to natural infection using different laboratory 
tests, many potential participants might be unaware of this, hence this will be perceived 
as a significant risk. 
The possibility of being included in a control group in the trial, where a placebo will be 
used instead of the my vaccine will also shift the risk-benefit ratio.in a rather negative 
direction. Researchers in Philadelphia have already reported that interest in participating 
in a vaccine trial amongst intravenous drug users dropped from 47% to 24% when the 
possibility of using a placebo was mentioned (Jenkins 1995: 37). 
Finally, a further risk inherent in an my vaccine trial is the possibility of increased risk-
taking behavior by participants who mistakenly believe that they have been protected by 
the vaccine. 
What are the benefits, if any, to trial participation? 
As scientists weigh the potential benefits of conducting atrial against the potential risks, 
so too will individual participants and target communities weigh relevant data before 
deciding to participate. This risk-benefit calculus. will ultimately be informed by social 
values. This is of special relevance to the Third World where in communities already 
"burdened by violence, drugs, alcohol, unemployment, urban decay and the like, the 
AIDS epidemic has merely exacerbated an already arduous burden of day-to-day 
survival. For many inner city residents the threat of random gunfire easily exceeds the 
somewhat less immediate threat of illY infection, a riskprofile that is difficult for 
outsiders to appreciate" (Hodel 1994: 255). 
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This sentiment is echoed by Virginia van der Vliet in her book "The Politics of AIDS", in 
a chapter entitled" The Savagery of Life: Powerlessness and Vulnerability":-
"Increasingly, those affected are the poor in urban ghettos, illegal migrants, drug users, 
street children, prostitutes, or the impoverished people in Third World countries~ They 
are not unacquainted with the savagery of life. For them, AIDS is just an additional 
problem, often faced with their customary fatalism. Fatalism is no protection against 
AIDS." (van der Vliet 1996: 77-78). 
It is against this backdrop offatalism that one needs to assess whether the development of 
a protective vaccine against AIDS will be perceived to be of overwhelming benefit to the 
Third World. 
Thus far the benefits cited have been located at two extremes of a narrow range oflimited 
possibilities. Subjects may be motivated to join a trial either on altruistic grounds or on 
grounds of personal benefit. 
A few studies have been conducted to date to assess the motivation of people to 
participate in trials. In one such study in Thailand, it was found that personal benefits 
were particularly important to the most willing group. This included additional direct 
benefits to study participation, primarily with respect to health care like long- term 
follow- up, provision of long-term care for non-vaccine related medical concerns. Purely 
altruistic motives were unrelated to willingness to participate (Jenkins 1995: 40-41). 
Similarly, another survey of2180 Thai people, found that the principal inducement to 
join a trial was health insurance (62% of subjects). These respondents indicated that a 5-
year family health insurance plan would encourage thein tojoin a trial (Celentano 1995: 
1079- 1082). 
Where mv vaccine trials are concerned, the risk- benefit ratio is situated in a rather 
precarious positJon. It is cleat to see that participants have little to benefit personally from 
such trials and potentially much to lose! 
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It is therefore not surprising that low levels of participation have been reported in trials so 
far. 
In a French vaccine trial, only 57 of 645 persons who had expressed initial interest by 
mail actually enrolled in the trial. Other surveys have found that under the relatively 
hypothetical condition of being asked to join a phase 2 or 3 mv vaccine trial, levels of 
willingness have ranged from 37% to 84%. 
Studies that have gone beyond asking the simple question of whether participants would 
be willing to join a trial have found that interest dropped dramatically when specific trial 
features or procedures were explained. 
A study of intravenous drug users in the New York City area found that the percentage of 
"very interested" potential volunteers dropped from 50% to 17% after they received 
information normally contained in a consent form. 
Another study found that 73% of those approached in Baltimore were interested in 
participation, although this figure dropped to 49% after the issue of testing HIV antibody-
positive as a consequence of immunologic response to the vaccine was discussed (Jenkins 
1995: 37). Both studies were conducted on people at high risk to develop HIV infection! 
Interestingly, studies are also finding that willingnes to participate in these trials is 
associated with lower levels of education. In a Thailand study of255 participants, high 
school-educated respondents were more willing to participate than university graduates 
(Jenkins 1995: 39). One wonders whether this choice not to participate by more educated 
respondents is not the result of a more accurate appreciation of the risk-benefit ratio 
inherent in these trials, namely the high risk- low benefit scenario. 
Of significance, in these studies of willingness to participate in trials, is the finding that 
the highest level of interest has been expressed in developing countries where the 
epidemic has universally impacted on kinship networks and community life - in Haiti and 
Kenya. This concept will be discussed in greater detail later. 
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A paper from Uganda highlights some of the issues that have been raised already. The 
potential difficulties associated with participation in research included the possibility of 
stigmatization as an individual with a particular disease, difficulties in obtaining 
transportation, the potential for a breach of confidentiality and ostracism by the patient's 
family or community. The primary benefit was that of potential access to medical 
treatment for the particular condition under study. It was concluded that patients would 
almost invariably agree to participate for this benefit alone, regardless of the potential 
risks associated with the research (Loue 1996: 51). 
An interesting point that has emerged from this discussion is that given full details of the 
risks and benefits of an mv vaccine trial, participants will either exercise their right of 
refusal to participate or will agree to pmticipate only if the benefit is maximised in terms 
of personal incentives, in particular health care, in the developing world. 
This raises the question of the extent to which the principles of beneficence and non-
maleficence should be maximised relative to the principle of autonomy but this will be 
explored later. 
A crucial factor to be considered here is that in order for the benefits to outweigh the 
risks in the trial of an mv vaccine, an individual would have to be at some risk ofillV 
infection. The necessity of being at risk therefore has scientific and ethical import. 
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4.4 Justice 
The principle of justice or fairness requires that the benefits and the burdens of research 
be equitably distributed among individuals or communities. No single group can be 
required to bear a disproportionate share of the risk or be favoured with a 
disproportionate share of the benefits (Loue 1996: 51) 
Under the principle of justice, research subjects should be chosen "for reasons directly 
related to the problem being studied," and not "because of their easy availability, their 
compromised position, or their manipulability." As a result, the "practical concerns that 
make an AIDS vaccine trial easier to conduct in Africa do not alone constitute sufficient 
justification to use Africans as subjects. Only the scientific concerns related directly to 
the problem of establishing the ability of a vaccine to prevent mv infection are 
relevant"(Christakis 1988: 36). 
Where mVI AIDS is concerned, it is evident that this disease is rampant in Africa. As a 
result, it may be unavoidable that a higher degree of research risk is tolerated in order to 
deal with the problem and this may even be socially sanctioned. However, this does not 
mean that Westerners should "indiscriminately benefit from research conducted in Africa 
if Africans are systematically subj ected to excess research risks with the prospect of 
deriving but little benefit. This would violate the principle of justice "(Christakis 1988: 
36). 
Where an AIDS vaccine is concerned, much of the world stands to gain from the 
development of an effective vaccine. In keeping with the principle of justice, those who 
stand to benefit from the vaccine should also bear the burden. Hence, the research risks 
should be fairly distributed as should the benefits. Vaccine development trials need not be 
restricted to the African continent . 
. In Africa, undoubtedly, much of the population stands to gain from the introduction of an 
effective vaccine. However, economic constraints may prevent adequate distribution of 
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such a vaccine. The benefits to Mricans are thus "only hypothetical unless there is a 
financial commitment by the developed world to provide the vaccine. In this light, it 
would be frankly unethical to subject Africans to a disproportionate share of the research 
risks" (Christakis 1988: 36) 
CIOMS Guideline 15 on Externally Sponsored Research requires that any trial "must be 
responsive to the health needs of the host country ... Any product developed through such 
research (should) be made reasonably available to the inhabitants of the host community 
or country at completion of successful testing" (Bloom 1998: 186-187). 
A contingency of any trial of an AIDS vaccine in Africa by Western scientists should 
thus be to provide access to the technology once it is developed - possibly in the form of 
free or subsidized vaccine (Christakis 1988: 36). 
In South Africa, the mv Vertical Transmission trials are an excellent example of the 
violation of the principle of justice in a research setting. In 1999, two years after the 
completion of these trials to find shorter courses of anti-retroviral treatment for mv 
infected pregnant women, millions of eligible women still go without treatment. It has 
clearly been shown that these shorter regimes of treatment are effective. Yet, there 
appears to be no funding forthcoming from the South Mrican government or from the 
developed world, in particular, the United States, who were involved in these research 
trials. 
In a paper published in the American Journal of Public Health, this issue is discussed 
openly. The outcome of the trials performed on impoverished populations around the 
world was clearly not the delivery of the necessary drugs to these developing countries. 
Instead, the purpose was "to provide information that the host country can use to make a 
sound judgement about the appropriateness and financial feasibility of providing the 
intervention"(Annas 1998: 561). This is ethically unacceptable. Good intent in the 
absence of a sound plan to provide the intervention, once proven to be effective, is no 
justification for the performance of such research 
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Annas goes on to say that "Unless the intervention being tested will actually be made 
available to the impoverished populations that are being used as research subjects, 
developed cbuntries are simply exploiting them in order to quickly use the knowledge 
gained from the clinical trials for the developed countries' own benefit. If the research 
reveals regimens of equal efficacy at less cost, these regimens will surely be implemented 
in the developed world. If the research reveals the regimens to be less efficacious, these 
results will be added to the scientific literature, and the developed world will not conduct 
thesestudies"(1998: 561). 
Hence, it is imperative that "African countries involved in the clinical trials must make 
realistic assurances that if a research regimen proves effective in reducing mother-to-
fetus transmission ofillV, resources will be made available so that the illY-positive 
pregnant women in their countries will receive this regimen"(Annas 1998: 561). 
Once again, with the proposed vaccine trials, South Africa has not clarified that it will 
conduct these trials on condition that a definite plan is in place to acquire the vaccine for 
widespread use, if it proves to be effective. 
Of note, however, is the fact that South Africa has decided not to conduct trials using a 
clade B vaccine which has already been developed in the United States. This viral 
subtype is not common in Sub-Saharan Africa but it is the predominant clade in North 
America where homosexual transmission ofillV is common. In South Africa, with a 
predominantly heterosexual transmission of disease, the predominant subtype is clade C. . 
South African researchers have opted to rather develop an appropriate clade C vaccine 
for experimentation here. Conducting trials of a vaccine that would have largely 
benefited the developed world would have been a clear violation of the principle of 
justice. 
Yet another way in which the principle of justice can be violated involves the counselling 
of trial participants to continue practising other preventative measures - like safe sex, 
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condom use, single partners - after the vaccine has been administered. With the 
promotion of these measures, it will be difficult to assess vaccine efficacy. These 
interventions could diminish the ability of the study to detect a difference between true 
vaccine recipients and controls by decreasing the incidence ofHIV infection in all 
participants for reasons unrelated to vaccine status (ChristakisI988: 34). On the other 
hand, failing to stress these measures could result in a greater risk of contracting mv 
infection, especially if the vaccine proves to be ineffective. 
To circumvent this problem, a larger study group would be required to detect the 
relatively smaller measured influence of the vaccine. Asa result, more individuals will be 
exposed to the experimental vaccine and the cost of the trials will be higher. It will also 
take longer to get statistically significant results. 
To prevent this potential harm to partici pants and in all fairness to them, it is imperative 
that researchers continue to promote preventative measures other than the vaccine. 
Finally, in Uganda, it was discovered that fairness to trial participants could potentially 
be affected when members of Institutional Review Boards or Ethics Committees and 
participants belong to different tribes. As a result, members of one tribe could potentially 
be over-researched and hence bear an unfair share of research risk. To overcome this 
problem, one needs to be cautious in how one constitutes review board or ethics 
committees (Loue 1996: 51). 
Hence, it is evident that there are many loopholes in performing ethical biomedical 
research, especially in the Third World. Under no circumstances should the principle of 
justice be violated in the design of an HIV vaccine trial. 
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4.5 Relevance of the Four Principles in Africa 
It is obvious from the preceding discussion that the principles are IIfar from 
. comprehensive and lack extensive guidance on issues of major importance, including the 
simultaneous maximisation of principles or the prioritizing of conflicting principles. 
Moreover, they are Western constructs and, as such, do not take into account local 
customs and traditions that should be respected and incorporated into the research process 
to the extent possible" (Loue 1996: 51). 
Respect for Autonomy: 
Respect for autonomy, in the African context differs significantly from the Western 
definition. This is so because the concept of personhood differs substantially. Where the 
embeddedness of the individual within society is emphasised, individual informed 
consent may be difficult to solicit. In such settings, proxy consent becomes important but 
should not take precedence over the wishes of the individual. Rather, the consent may 
have to be obtained jointly or after time has been allowed for consultation with 
significant others. In a Third World setting, this may entail travelling to rural homes and 
allowances will have to be made in this regard. 
The information element of informed consent will also differ significantly in Africa. 
Written information as well as written consent may be inappropriate in the context of 
high rates of illiteracy. As a result, information will have to be available in oral or visual 
forms. Language barriers are unavoidab Ie and hence all information regarding the trial 
will have to be available in the language/s of the trial participants. Interpreters, from 
within the target communities, will be indispensable. It will also be essential that all 
scientific and research protocols are explained in culturally relevant terms. 
In a Third World setting the pre-condition of voluntariness in soliciting informed consent 
is crucial. This is so because socio-economic deprivation renders participants vulnerable 
to the most subtle forms of influence. It is thus essential that participants are reimbursed 
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for losses sustained directly related to trial participation. Anything in excess ofthis will 
be seen as extraordinary and will constitute an unfair inducement. 
The concepts ofvoluntariness and informed refusal are also affected if resources are 
limited and if research is conducted at academic hospitals. Patients often have no 
alternatives for treatment and feel compelled both to consent and participate. These 
relatively few centres of excellence in the field of health care are held in high regard as 
are the medical staff of these institutions. As a result, patients will comply with requests 
for participation in research as an indication of respect and gratitude for health services. 
In such settings, informed consent is less than voluntary. 
Finally, under the principle of autonomy, competence to give informed consent in the 
Third World is becoming a volatile issue. More and more, it is being realized that in 
"most settings in Afhca, informed consent will be problematic and difficult, and it may 
even preclude ethical research. This is because, in the absence of health care, virtually 
any offer of medical assistance (even in the guise of research) will be accepted as "better 
than nothing" and research will almost inevitably be confused with treatment, making 
informed consent difficult" (Annas 1998: 562). 
Support for this conclusion was elicited in interviews with trial participants in the Ivory 
Coast where it was found that "many of the participants did not understand the 
implications of the trial, even though they gave their consent". In the words of an African 
researcher, "in an environment where the majority can neither read nor write and is 
wallowing in poverty and sickness, hunger and homelessness, and where the educated, 
the powerful, the rich, or the expatriate is a semi-god, how can you talk of informed 
consent?"(Zion 1998: 1330). 
While such a viewpoint is regarded as paternalistic, it may nevertheless reflect the reality 
of research in Africa. This, however, should not preclude ethical research in Africa, but 
should be remedied in the form of widespread education campaigns so that, in time, it 
will be possible to elicit informed consent from truly competent research participants. 
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Non-maleficence and Beneficence: 
In the context of Third World settings in Africa, balancing these two principles in the 
form of the risk-benefit ratio has already been shown to be problematic. The odds are 
leaning heavily in the direction of high risk-low benefit especially if the intervention 
being tested is not made available to the Third World after the trials. The risks to the 
individual are many and serious. Apart from the usual physical or medical adverse 
effects, social harms are significant in Africa, where much stigmatisation is attached to 
having illY/AIDS. 
The benefits, while appearing to be significant in terms oftheillV/AIDS pandemic, are 
minimalised by the ethos of fatalism in those communities who bear the brunt of this 
devastating illness. Under these circumstances, it appears as though only those at high 
risk of developing HIV/AIDS will derive benefit. The risk-benefit ratio can also be 
viewed in terms of the Belmont Report which requires that "risks to subjects be 
outweighed by the sum of both the anticipated benefit to the subject, if any, and the 
anticipated benefit to society ... "(Christakis 1988: 35). 
Any principles which prevent harm to research subjects and demand their beneficient 
treatment are particularly relevant in a Third World setting where vulnerable subjects 
need more protection than usual. Without such stringent ethical guidelines, these subjects 
run the greatest risk of exploitation by rich and powerful developed nations. 
Justice: 
The fair distribution of the benefits and burdens ofillV vaccine research in Africa is an 
absolute requirement of ethical research. The higher incidence of mv / AIDS in Africa 
does justify a higher tolerance of risk but not to the detriment of the African people. If the 
only people who will benefit from vaccine research are the developed nations of the 
world, this research cannot be justified in Africa. It is therefore imperative that a definite 
plan is in place to ensure that a vaccine, if found to be effective, will be made available to 
the people who need it most and who have borne the brunt of a very risky research trial. 
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Undoubtedly, the basic ethical principles that guide human investigation, as defined by 
the Helsinki Declaration and the Nuremberg Code, need to be interpreted and applied 
within different cultural settings. 
In Africa, "making respect for autonomy a trump moral principle, rather than one moral 
principle in a system of principles, gives it an excessive value ... In many clinical 
circustances the weight of respect for autonomy is minimal, and the weight of 
nonmaleficence or beneficence is maximal. Similarly, in public policy, the demands of 
justice can easily outweigh the demands of respect for autonomy"(Beauchamp and 
Childress 1994: 181). 
In the Third World, it appears as though the principles of beneficence, non-maleficence 
and justice should be maximised relative to the principle of autonomy. It is obvious that 
by using material inducements to shift the risk-benefit ratio in a positive direction, 
voluntariness ofinfonned consent is compromised. However, fair distribution of the 
benefits of the research, in the form of an effective vaccine, would justify some of the 
research risk taken by impoverished Third World populations. At the same time, sincere 
efforts to obtain truly informed consent should not be abandoned. 
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5. Research and its limitations on the moral interests of subjects 
The discussion thus far has illustrated that medical research involving human subjects 
creates conflicting values. On the one hand, we seek to enhance the general welfare of 
society by expanding our generalizable medical knowledge - the development of an 
effective mv vaccine will meet this objective.Onthe other hand, the traditional nature 
of research studies may unavoidably involve some compromise of the moral interests-
the rights and welfare - of human subjects. 
These moral interests fall into three categories: 
1. the interest in exercising the capacity for moral choice 
2. the interest in avoiding harm 
3. the interest in fair treatment 
Acceptable limitations on these moral interests need to be established. This may be 
achieved with the following moral framework proposed by Ackerman and Strong: 
1. The Social Benefit View 
Here, limitations on moral interests may be tolerated if they promote the interests of 
research. The benefit of generalizable medical knowledge takes precedence over the 
rights of the individual. Carried to its logical conclusion, it would permit unacceptable 
violations of the rights and welfare of individuals as occurred in the Tuskegee 
experiment. This is by far an inadequate approach and will not be examined further. 
2. The Subject-Oriented Approach 
. The moral interests of the su bj ect are given priority over the interests of research. This 
approach emphasizes informed consent, limitation of risk and fair treatment of subjects. 
Research will be permitted only if these requirements are satisfied. 
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3. The Balancing Approach 
Using this strategy, the social benefits of medical research and the moral interests of 
subjects are integrated. This approach forms the basis of the Belmont Report in which the 
risk to the subject must be outweighed by both the benefit to the subject and the benefit to 
society. The risk-benefit profile affecting the immediate subject is usually given special 
weight. It is clear that in assessing this balancing process, the degree of risk at which 
subjects will be placed, will be pivotal. 
Problems related to Consent: 
As discussed previously, the elements of information, comprehension and voluntariness 
are critical in obtaining informed consent. Each of these elements may be explored 
looking at the subject-oriented view as opposed to the balancing approach. 
Information 
The moral interests of a subj ect might be at issue if limited or inadequate information 
were provided~ In the context of the mv vaccine trials, if participants were NOT told that 
they would NOT be able to participate in future vaccine trials, this would constitute 
limited Or inadequate information. 
A subject-oriented view requires strict observance of the information condition. 
Deceptive nondisclosure of pertinent information would be prohibited because subjects 
are deprived of "their right to decide freely and rationally how to invest their time and 
persons". It would thus be impermissible to ask subjects to consent to the nondisclosure 
described above. 
By contrast, a balancing approach would permit nondisclosure of information if it is 
necessary to achieve research objectives and subjects will not be placed at significant 
risk. Here, while there is some risk involved in participating in trials ofless developed 
vaccines, being denied the opportunity of participating at a later stage, with a more 
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advanced and hence more effective vaccine, relatively speaking, might not constitute a 
significant risk to the individual. In this hypothetical case, if this information were 
disclosed, initial trials might never start, if all potential participants waited fora better 
vaccine. 
On the other hand, if trial participants were NOT told that they would NOT receive 
treatment if they developed mY/AIDS during the course of the trials, this nondisclosure 
would place the subjects at considerable risk and could not be justified using either the 
subject-oriented view or the balancing approach. 
Comprehension 
If, in the course of obtaining informed consent, it was discovered that a potential 
participant, due to educational and cultural factors, could not understand the details of the 
scientific process involved in research in terms of randomisation, blinding, placebo-
control- even though it was explained in simple terms - but was prepared to give consent 
nevertheless, how could this be justified? 
For a subject-oriented approach, valid consent must include adequate comprehension of 
the consequences of involvement. This participant may not be able to appreciate the 
consequences of receiving placebo. The consent obtained would not be valid and, s/he 
should not participate in the trial. In Africa, this would exclude a significant number of 
potential participants, perhaps to the extent that vaccine research may not be scientifically 
valid due to small numbers participating in the trials. 
A balancing strategy may permit less than fully adequate comprehension when the latter 
is unavoidable and participation in research will not seriously compromise the subject's 
welfare. However, even this approach could not justify proceeding with the consent, 
because the risk to the participant in an HIV vaccine trial is great and comprehension of 
this risk cannot be compromised. Without the vaccine, of course, the participant and 
society at large, is also at risk and perhaps the lesser of two evils need to be considered. 
In the absence of educational upliftment in Mrica, this might become a necessary option. 
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Voluntariness 
A study conducted in Thailand and referred to earlier explores the issue of providing 
incentives like a 5- year health insurance plan to potential trial participants in an mv 
vaccine trial. 62% of participants agreed to participate if they could receive this incentive. 
Is this justifiable? 
A subject-oriented approach requires that the subject's decision to participate represent an 
adequately voluntary choice. To ensure that the decision reflects the subject's values and 
interests, one would have to appeal exclusively to the subject's willingness to accept risks 
or inconveniences for the benefit of society. This means that payment offered should be 
restricted to fair compensation for the time expended and the inconveniences endured by 
the subject. Payment should not be so high as to provide an independent motive for 
participation. 
A balancing strategy may not regard the use of an incentive as an unacceptable 
compromise on the voluntariness of choice. Payments for research participation may be 
set at levels necessary to secure the required number of sub] ects, provided that subjects 
will not be placed at significant risk. 
Problems Related to the Risk of Harm 
The following protective conditions safeguard the welfare of research subjects: 
1. not exposing subjects to the risk of harm without their consent 
2. preventing harms that may be unnecessary or inappropriate - this requires that human 
subjects should 110t be used when research objectives can be achieved without their 
involvement; that the least risky procedures are used and that the risks are reasonable in 
relation to anticipated benefits 
3. ensuring that doctors relieve the harms caused by disease when providing treatment in 
the research setting. 
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In isolating incremental harm, one may distinguish between therapeutic and non-
therapeutic research procedures: 
Therapeutic research procedures are intended to benefit subjects, as well as to contribute 
to the achievement of research objectives - the mv vaccine is an example. If this 
treatment modality is not as effective or safe as an alternative treatment, then it may carry 
a risk of incremental harm. 
Non-therapeutic research procedures are only intended to contribute to the achievement 
of research objectives; they are not intended to benefit subjects - such as medical 
procedures like venepuncture or bone marrow aspirations. Hence any associated risks are 
incremental. 
Moral problems related to the welfare of research subjects arise when the subject's 
limited capacity to consent or the design of the research project requires modifications to 
the protective conditions described above. 
A subject-oriented view would not allow the pursuit of social benefits of the medical 
research to modify these requirements. Investigators may not expose subjects to risks of 
incremental harm when performing either therapeutic or non-therapeutic procedures 
unless they give adequately informed consent. Unnecessary exposure of subjects to risk 
must be prevented. Finally, therapeutic research procedures must not be used if they 
provide less than optimal treatment. 
A balancing approach will allow partial fulfillment of the protective conditions if it is 
necessary to achieve research objectives and if the well-being of subjects is not 
significantly compromised. 
When the protective conditions are breached, the subject-oriented as opposed to the 
balancing approach have very different practical implications: 
1. Breach of the condition that only consenting subjects be exposed to incremental risk. 
Such a situation would arise if repeated blood tests were to be done on the children of 
mothers who were given the mv vaccine during pregnancy, hypothetically speaking. 
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Using a subject-oriented view, the use of "minimal- risk", non-therapeutic procedures is 
permissible because they create no incremental risks for. non-consenting subjects. 
"Minimal risk" is defined as the probability and magnitude of harm that is "ordinarily 
encountered in daily life or during the performance of routine physical or psychological 
examinations or tests". In the above instance, the blood tests would be permitted. If, 
however, the children had to have bone marrow aspirates, this would not be permissible 
as it would constitute more than minimal risk. 
Using a balancing approach, on the other hand, non-therapeutic procedures involving 
more than minimal risk may be used only if there is a minor increase over minimal risk 
and the interventions are likely to be familiar to children with the disorder being studied. 
In addition, the study must be necessary to produce knowledge about the subject's 
disorder that is vitally important. 
Hence it is clear that where subjects are unable to consent, the rules are extremely strict, 
even if the balancing approach is used. 
2. Breach of the condition that the harms that subjects will be exposed to will be 
minimised. 
This situation would arise ifit were decided that South African subjects would be used to 
test a vaccine made from a viral subtype that does not occur in South Africa (Soal 1998: 
17). 
The acceptability of this study could be challenged on two grounds. Firstly, the subject-
oriented view would have a strict requirement for consent to such risk. This approach 
would question why a prospective subject would willingly and knowingly consent to a 
risky trial that is unlikely to benefit South Africans. A proponent of the subject-oriented 
approach might insist that an appropriate vaccine made of a local viral subtype be used to 
avoid exposing subjects to any unnecessary and inappropriate risk. 
The balancing approach, by contrast, might see the risk as reasonable if benefit accrues to 
humanity, in general, in another pal1 of the world where the particular viral subtype is 
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common. Also, the possibility of cross-clade reactivity across different subtypes has not 
been tested and might work, conferring benefit to South Africans as well. The protective 
condition ofthe harm-benefit ratio might be waived in this instance in view of the 
anticipated benefit to society. 
3. Breach of the condition that investigators not provide less than optimal treatment 
when providing therapy in the research setting 
This particular problem cannot be applied to the proposed vaccine trials as there are no 
equivalent or optimal vaccine options at present. Also, the vaccine is a prophylactic 
rather than a therapeutic modality and there is no data available yet on the optimal 
vaccine. If, however, more than one vaccine option becomes available, the subject-
oriented view would require that the physician inform the patient of which treatment 
alternative offers the most favorable risk-benefit ratio for the patient. This suggests that 
physicians who believe that the treatment arms of a randomised clinical trial are not 
equally favorable should not recommend participation to their patients. This has serious 
implications for placebo controlled trials because participants run the risk of no treatment 
during their participation in the trial. A subject-oriented view in this regard would favor 
non-participation. This would seriously retard the progress of scientific research. 
Use of a balancing strategy may lead to less stringent conditions for involvement of 
subjects in randomized clinical trials. Requiring physicians to make treatment 
recommendations can seriously impair efforts to accrue enough subjects who accept 
randomization, because they are more likely to want the treatment preferred by their 
physician. Furthermore, withholding a treatment recommendation will not significantly 
compromise the welfare of subjects, because randomized clinical trials are not justified 
unless investigators can honestly state that there is no scientifically validated reason for 
preferring one of the treatments being compared, Thus, a balancing approach may allow 
investigators to seek participation of subjects in the randomized clinical trial without 
sharing their treatment preferences. 
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Problems Related to Fair Treatment 
Medical research is a cooperative social endeavour subject to the requirements of 
distributive justice. In order to ensure equal opportunity, some classes of subj ects may 
have to be treated differently from others in the distribution of protective mechanisms. 
Subject-oriented and balancing approaches will assign different weight to fair treatment 
in the conduct of research. These contrasting approaches will lead to different 
conclusions on a variety of justice-related issues. 
1. . Do economically disadvantaged subjects need special protections to prevent 
constraints on autonomous choice caused by undue inducement? 
This issue has been raised in the context of proposed vaccine trials in Africa where 
economically-disadvantaged people might be offered inducements to participate, such as 
a health care plan or monetary payment. 
A subject-oriented approach would require that economically indigent persons should be 
provided with stronger protections because they are especially vulnerable to monetary 
inducements. This might entail reducing the amount of compensation offered or using 
more economically advantaged research participants. 
A balancing strategy might permit the use of incentives if it is necessary to achieve 
research objectives and the subjects' welfare is not significantly compromised. 
2. Should injured research subjects be compensated? 
In the context of the HIY.vaccine trials this issue relates to whether subjects who develop 
mv / AIDS should receive anti-retroviral treatment or not. 
A subj ect-oriented view involves the straightforward application of the notion of fair 
treatment. According to Ackerman and Strong, harms incurred by research subjects are 
burdens resulting from participation in a cooperative social endeavour. Subjects who 
develop mv/ AIDS will be less able to pursue their life plans than non-affected subjects. 
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Provision of treatment constitutes a useful mechanism for redressing the inequality 
caused by their illness. This approach favors the treatment of those who develop 
HIV/AIDS during the course of the trials. 
On the other hand, the balancing approach questions the appropriateness of compensation 
for harm sustained in the course of research. The cost of such an exercise might drain 
already limited research funds. Retroviral treatment is exorbitantly expensive, especially 
if state of the art triple therapy is provided. Furthermore, proponents ofthis approach feel 
that the risk of harm is offset by the special advantages associated with participation in 
research - the treatment being evaluated often represents the best option for dealing with 
a life-threatening illness; nursing care is often more intensive and specialised in the 
research setting and the research centre often provides access to a variety of specialists 
and services for diagnosis, monitoring and rehabilitation. In this event, even if a subject 
sustains harm from a research procedure, it may have constituted the option of treatment 
with the best harm-benefit ratio. The balancing approach might compensate harms caused 
by non-therapeutic interventions but not harms due to therapeutic interventions. 
Society, Subjects and Medical Research 
It is abundantly clear from the preceding discussion that the subject-oriented and the 
balancing approaches yield completely different and often opposing conclusions 
regarding the moral restrictions that should circumscribe the conduct of medical research. 
Ackerman and Strong go on to show how these two approaches represent profoundly 
different views regarding the role of society in research, the expectations placed on its 
members and the importance of medical research as a societal venture (Ackerman and 
Strong 1989: 166-179). 
The subject-oriented approach reflects three basic assumptions: 
1. The basic role of society is to implement norms of behavior that protect its members 
from violation of their moral interests by other persons. 
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2. Society can expect of its members that they will observe these basic rules for 
protecting the moral interests of each person but society should not require that its 
members participate in any particular kinds of social activities. 
3. Medical research is not ordinarily essential to the preservation of society. 
From these basic assumptions, it can be concluded that the benefits of medical research 
should be treated by society as highly desirable but morally optional. As such, society 
should not require participation of its members in research. 
A balancing view starts from a very different set of assumptions: 
l. Society has the general function of providing the essential conditions its members 
need to pursue their life plans. These conditions include protection against 
exploitation by others, but also involve the provision of the essential goods people 
must have to pursue their life plans, like housing, nutrition, education and health care. 
2. The provision of essential resources to all members of society can only be secured 
through social co-operation. Hence, all individuals are expected to assist in their 
production. Constraints on the moral interests of individuals may be necessary in 
order to provide all persons with essential goods. 
3. The essential resources persons need to pursue their life plans include adequate health 
care. Medical research contributes to the growth of medical knowledge. Hence, 
medical research is an essential component in providing adequate medical care to the 
members of society. 
These assumptions suggest a different approachto the use of human subjects'" society 
should formally sponsor clinical investigation and society should set expectations for the 
involvement of its members in clinical research. 
The' choice between these two conflicting approaches inthe use ofhum,!n subjects will 
reflect the moral significance of vulnerability, interdependence and sociability in human 
relationships. 
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Vulnerability: 
Here we look at the extent to which persons misuse those who are more vulnerable than 
themselves. The Tuskegee Syphilis Study provides an excellent illustration of this 
phenomenon. Where the chance of researchers exploiting subjects is great, over-riding 
weight is given to the subject-oriented approach. If, on the other hand, researchers will 
modify protective conditions with sensitivity and responsibility, a balancing approach 
would be favored. 
Interdependence: 
The perceived dependency of persons on one another for basic goods and resources is 
another important factor. If many persons are highly dependent on others for goods or 
resources, a balancing approach would be favored. If, conversely, persons are confident 
to pursue their life plans independently, provided with basic protections for their moral 
interests, then a subject-oriented view is preferable. 
Sociability: 
This factor examines the compatibility between the values and interests of particular 
individuals and the needs of other members of society. If it is felt thatthe needs of 
individuals may diverge from the needs of other members of society, a subject-oriented 
view would be chosen to protect the values and interests of each person. However, if 
some interest in the general welfare of others is considered essential to the personal 
fulfillment of each individual, a balancing approach would be preferable (Ackerman and 
Strong 1989: 166- 179). 
Ultimately, these two conflicting approaches have their origins in two broad based 
theories in ethics - liberal individualism as opposed to a form of moderate 
communitarianism and this opposition will be examined in the next section. 
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7. Trial Participation - the tension between liberalism and communitarianism 
The review of the subject-oriented view as opposed to the balancing approach clearly 
indicates that the subject-oriented view is in keeping with the ethos of Liberal 
Individualism. Protective conditions for consent, the risk of harm and the fair treatment 
of subjects cannot be waived. 
According to Ackerman and Strong, the subject-oriented view is a dominant approach in 
the context of exploitation of the poor and vulnerable. In South Africa, as we emerge 
from a history where the rights of the vulnerable and poor have been negated in the 
service of apartheid, the preference for a subject-oriented view, where research is 
concerned, is a logical choice. Our new democratic order, our Constitution and Bill of 
Rights bear testimony to this. Liberal Individualism has reached South Mrica also! 
This is the liberal democracy that Fukuyama sees as "the endpoint of mankind's 
ideological evolution", the "final form of human government" and as such, the "end of 
history" - where history is seen as a single, coherent, evolutionary process - in a 
Hegelian tradition. In this tradition, the "evolution of human societies was not open-
ended, but would end when mankind had achieved a form of society that satisfied its 
deepest and most fundamental longings". As such, there would be "no further progress in 
the development of underlying principles and institutions, because all the really big 
questions had been settled" (Fukuyama 1992: xi-xxiii). 
Fukuyama believes that the greater part of humanity will be led to liberal democracy-
for two reasons. Firstly, it results in a stable economy and secondly, it provides an answer 
to the "struggle for recognition". 
Economically, liberal principles like the free market have "spread and succeeded in 
producing unprecedented levels of material prosperity, both in industrially developed 
countries and in countries that had been .... part of the impoverished Third World". 
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However, Fukuyama finds economic interpretations of history incomplete and 
unsatisfying, because "man is not simply an economic animal". For the sake of 
completeness, we need to examine man's "struggle for recognition". 
This struggle for recognition is based on man's need to be "recognised as a human 
being .... as a being with a certain worth or dignity". Of the three parts of the soul 
described by Plato - the desiring part, the reasoning part and thymos or spiritedness - the 
propensity for self-esteem arises from thymos. Fukuyama describes it as an "innate 
human sense of justice". Humans believe that they have a certain worth. When this is 
negated, they become angry; when this is reinforced, they feel pride. It is this thymos 
which ultimately drives the historical process. 
Liberal democracy - according to Fukuyama - replaces the irrational desire to be 
recognised as greater than otners with a rational desire to be recognised as equal. 
However, critics ofliberal democracy believe thatthe universal recognition is incomplete 
because capitalism creates economic inequality. Hence, liberal democracy "recognises 
equal people unequally". Is liberal democracy then not "prey to serious internal 
contradictions, contradictions so serious that they will eventually undermine it as a 
political system"? (Fukuyama 1992). 
In the discussion of ethical issues related to research in the Third World, we have seen 
many such internal contradictions in the theory of Liberal Individualism. Most striking is 
the fact that a strict adherence to a subject oriented approach ultimately renders research 
impossible and this will ultimately lead to the decline of the individual I 
In South Africa, a tension exists between the new democracy and the old tradition of 
communalism or Ubuntu even though the latter exists in a much diluted form due to the 
spread of liberal individualism. 
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Unlike the subject oriented approach, the balancing approach is more closely aligned to a 
sense of society or community - medical research is seen as one of the essential goods in 
a society and is therefore vital to the survival of such a society. 
Chiistakis comments that an African might find it "difficult to see how the interests of the 
subject conflict with the interests of the society except, of course, if the society is not his 
own". In traditional Mrica, the interest of the subject and of society are necessarily 
congruent. 
This is in keeping with the Nguni belief that "umuntungumuntu ngabantu" - a person is 
a person through persons. Each individual member of the community sees the community 
as themselves, as one with them in character and identity. There is no room for a 
separation between the individual and the community; People see themselves as 
"potential persons" who become fully human to the extent that they are included in 
relationships with others (Shutte - unpublished data). 
Alasdair MacIntyre, using somewhat different concepts describes a similar connectedness 
to the community when he describes a virtue-based morality for life in the post-
Enlightenment period. Much of this results from his disillusionment with the 
Enlightenment project in general and with Enlightenment morality, in particular, which 
. he sees as non-existent. In his account of a "unitary core concept of the virtues" he 
describes a "practice", the "narrative order of a single human life" and he situates these in 
the context of "a moral tradition". The third stage is essential because "we are all bearers 
of tradition, we function within, and gain our social identity through membership in 
communities. Against the type of modern theory of individualism which speaks as if each 
of us is a separate and discrete individual ... ,MacIntyre is helpful in reminding us of our 
historical situated ness and social identities" (Bernstein 1982: 115-140). 
Ultimately, the dilemma we face in the mv Vaccine Trials is one of modernism, where 
universality and individualism are stressed, as opposed to postmodernism, where 
particularity and community or context is a dominant feature. 
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8. Trial Participation -Ubuntu, our only hope, or Ethical Relativism? 
There is no doubt that Mrica, and South Africa, in particular, is an ideal site for mv 
vaccine research in view of the mV/AIDS epidemic we are currently experiencing. 
We have seen that the mv Vaccine Trials pose a grave and significant risk to the 
individual who may subsequently have little to gain. Under such circumstances, 
statistically significant trial participation can only be ensured by an appeal to altruism, in 
the African context, Ubuntu. In this regard, the interests of science and society are seen as 
one with the interests of the individual. Interdependence and connectedness is a 
prominent feature of traditional African society. In such a setting, trial participation and 
hence medical research will be possible. 
However, with the influence of Western Liberalism, an appeal to Ubuntu is not going to 
be easy. The principle of autonomy is becoming slowly but firmly entrenched in Africa. 
A retreat to Ubuntu will be seen for what it is - a convenient retreat to a comfort zone to 
suit the whims and fancies of Western researchers. 
It would appear that the West has realized that their very own concept ofliberal 
individualism, which has generally worked well for them, is becoming problematic as a 
result of its spread to Mrica. Having developed a strong sense of self-preservation in 
keeping with the ethos ofliberal individualism, it appears as if they want to retreat from 
their universal principles of equality and liberty to "different", local standards of care. 
This can only be achieved if some ofthe"rules" are changed and the World Medical 
Association is taking the lead in attempting to amend the Declaration of Helsinki. 
The draft revisions of the Declaration of Helsinki, in particular, section18, qualify the 
insistence that all participants, including controls, be 'assured of the best proven 
diagnostic and therapeutic method' by adding the rider that such interventions only refer 
to those 'that would otherwise be available to him or her'. In other words, the ideal of a 
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universal 'gold standard' of treatment would be abandoned in favour of a standard 
dependent on local conditions (London 1999: 812-813). 
As a result, in terms of the mv Vaccine Trials, participants who develop mV/AIDS in 
the course of the trials will not be treated with anti-retroviral drugs as this would 
otherwise not be available to him or her in South Africa. This would represent an 
enormous saving to multinational drug companies involved in vaccine research as they 
potentially have the most to gain from such vaccine trials, especially if they are 
conducted cheaply in Africa. 
The proposed revisions to the Declaration of Helsinki reek of ethical relativism. 
Such relativism threatens to "institutionalise global injustice in the application of ethical 
standards" (London 1999: 812). 
The core of the ethical dilemma now confronting the 'West', as it attempts to realise its 
domestic and global agendas around the world, is one of cultural conflict. 
The Western concept ofliberal individualism (amongst others) conflicts head-on with 
Confucian, Cantonese, Hindu, Bhuddist, African, Islamic, and other cultural influences 
that dominate globally (67% of the global population is non-Christian). For example, the 
Chinese, who number 1,254 billion people and form the largest cultural group on the 
planet (World Population Data Sheet 1999) have their own system of ethics. For 2500 
years Confucian ethics was the dominant moral philosophy and ideology of Chinese 
culture. Ancient Chinese medical ethics is based on Confucian ethics. It has strong 
deontological features and is virtue-based. Humaneness forms the core of its principles 
(Tsai 1999: 316-317). The community and family take precedence over the individual in 
such dominant and mature value systems worldwide. 
The West has recognised this, and is now attempting to make its global 'missionary' 
efforts more effective by mutating Western concepts like liberal individualism, and 
others, to form hybrid concepts that are more palatable to the "heathens", as a means to 
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realising Western agenda's anyway! It is not surprising that this often results in human 
rights abuses in the first and third world al ike. 
In rural Africa, an appeal to Ubuntu could succeed in harnessing trial participation. 
However, in the developed areas of Africa, where individualism is spreading, this might 
not be possible. 
/ 
'. 
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9. Conclusion 
As anticipated, participation in the proposed mv Vaccine Trials in South Africa will be 
. riddled with ethical concerns. The area expected to be most problematic relates to respect 
for autonomy and informed consent. In South Mrica, this process will not always involve 
the individual but significant others may also be consulted by trial participants. 
Information will have to be presented in a culturally relevant form and written 
I 
information and consent will be problematic in the context of high rates of illiteracy. 
Voluntariness must be preserved when dealing with vulnerable populations and the use of 
extraordinary incentives will certainly constitute undue influence. Finally, in this regard, 
competence becomes questionable when significant understanding of complex scientific 
details is required of people who are educationally disadvantaged. 
In preserving the principles of beneficence and non-maleficence, the risks to potential 
trial participants, both medical and social, outweigh the perceived benefits. Any benefit 
to be gained will be gained by high- risk participants only or if benefit to the individual is 
combined with societal benefit and then weighed against risk. The high risk profile of 
these trials would negate the principle of justice if the possible benefits of the trial in the 
form of a free or subsidised vaccine were not made available to the people who 
volunteered to bear the burdens of this research. Similarly, if participants developed mv 
infection in the course of the trials and were not given treatment, the principle of justice 
would also be violated. 
If the principles in which the Declaration of Helsinki is grounded are strictly adhered to, a 
subject-oriented approach would be favoured. Constraints on the rights of the individual 
will be impermissible and in the Third World, this would render research unethical and 
hence, impossible. Conversely, many of the world's dominant cultures allow 
infringements on the rights of the individual to produce societal good. This, coupled with 
a limitation on the risk to the individual, constitutes a balancing approach which sees 
research as an essential requirement for the survival of all of mankind. 
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Hence, it is evident that it is problematic to pursue an individualistic view, perhaps in 
general, but especially where research in the Third World is concerned. 
This does not imply that the ethical guidelines which already exist and which protect the 
interests of research subjects should be abandoned. Nor should one aim for universality 
of existing Western principles because the global population is not homogenous and 
universality "obscures and obliterates the particularity and specificity of morality which 
is grounded in communal traditions"(Bernstein 1981). For example, ifautonomy is to be 
viewed as a truly universal principle, is it not possible that the "North American 
paradigm is only one version of it"? It is therefore unnecessary for "every country to 
follow the practice of autonomy in all of its details in a fashion identical to that found in 
North America" (Akabayashi 1999: 299). 
The Four Principles Approach provides a valid framework in which to consider the 
various ethical issues but, as a Western construct, does not "take into account local 
customs and traditions that should be respected and incorporated into the research 
process" as far as is possible (Loue 1996: 51). So, although incomplete, it is not 
incompatible with values in other cultures. Compared with Ancient Chinese medical 
ethics, there is considerable overlap except where autonomy is concerned (Tsai 1999: 
316-317). 
As such, culturally relevant ethical issues need to be incorporated into existing 
frameworks to augment them with cultural sensitivity. However, changing the rules from 
time to time and fi'om place to place to achieve the research aims of the West will be both 
unjustifiable and morally reprehensible. Furthermore, fulfilling the additional 
requirements will be time-consuming, whether this takes the form of massive education 
campaigns to reduce educational inequalities between first and third world communities 
or additional time for consultation with family prior to providing informed consent. 
While this may also be costly in economic terms, Western researchers and multinational 
drug companies will have to realise that they too have a responsibility in reducing the 
inequities between first world and third world communities. 
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Undoubtedly, the HIV Vaccine Trials in South Mrica will pose a major ethical challenge 
to all involved. We must, however, be wary that in our haste to develop and test an HIV 
vaccine, we do not cause an ethical catastrophe that we will never be able to justify. It has 
taken a long time for the research community to recover from Tuskegee. May we never 
tread along that path again! 
Ultimately, the dilemma we face is the application of "Modern" ethical principles and 
theories to a "Postmodern" world. Unlike the objectivity, universality, rationality and 
individualism emphasized in Modern or Enlightenment ethics, the postmodern period in 
which we live demands subjectivity, particularity, sensitivity to context, cultural 
tolerance and positive deconstruction of existing norms. It is only by embracing a 
postmodern approach and by taking what is good out ofmodemity that medical 
researchers, globally, will enter the new millennium to meet the ethical challenges which 
lie ahead, with integrity and moral responsibility. 
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